HomeMGX • NASDAQ
add
Metagenomi Therapeutics Inc
Previous close
$1.44
Day range
$1.40 - $1.48
Year range
$1.23 - $3.95
Market cap
55.30M USD
Avg Volume
266.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 3.91M | -59.32% |
Operating expense | 6.78M | -4.18% |
Net income | -22.53M | 3.72% |
Net profit margin | -576.02 | -136.68% |
Earnings per share | -0.60 | 4.76% |
EBITDA | -23.07M | -20.38% |
Effective tax rate | -0.15% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 160.80M | -35.24% |
Total assets | 221.10M | -31.88% |
Total liabilities | 62.51M | -30.35% |
Total equity | 158.60M | — |
Shares outstanding | 37.62M | — |
Price to book | 0.34 | — |
Return on assets | -25.98% | — |
Return on capital | -29.05% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -22.53M | 3.72% |
Cash from operations | -23.55M | 10.39% |
Cash from investing | 32.37M | 13.39% |
Cash from financing | 74.00K | — |
Net change in cash | 8.89M | 291.98% |
Free cash flow | -17.46M | 10.82% |
About
Founded
2016
Headquarters
Website
Employees
119
